Doorgaan naar hoofdnavigatie
Doorgaan naar zoeken
Ga verder naar hoofdinhoud
Sorteer per
Keyphrases
3-year Survival
25%
Abdominal
25%
After Surgery
25%
Alpha-fetoprotein
25%
Anemia
25%
Anorexia
25%
Area under the Curve
50%
Before Surgery
25%
Cancer Research
50%
Carboplatin
50%
Chemotherapy Cycles
50%
Cisplatin
50%
Cisplatin-based Chemotherapy
100%
Complete Remission
75%
Documented Infection
25%
Dose-dense
100%
Doxorubicin
75%
End of Therapy
25%
End of Treatment
50%
Event-free Survival
25%
Extrahepatic Disease
25%
Febrile Neutropenia
25%
Fungal Infection
25%
Gross Total Resection
25%
Hematotoxicity
25%
Hepatectomy
25%
Hepatoblastoma
100%
High Risk
100%
Intention-to-treat
25%
Liver Metastasectomy
25%
Liver Segment
25%
Liver Transplantation
25%
Lung Metastasis
25%
Metastatic Disease
25%
Microvascular Invasion
25%
Moderate to Severe
25%
Mucositis
25%
Neutropenia
50%
Newly Diagnosed
25%
One-child
50%
Ototoxicity
50%
Partial Response
25%
Postoperative Chemotherapy
25%
Preoperative Chemotherapy
75%
Radical Surgery
25%
Serious Adverse Events
25%
Single-arm Feasibility Study
100%
SIOPEL
100%
Surgical Removal
25%
Switzerland
25%
Thrombocytopenia
25%
Treatment Regimen
50%
Tumor
50%
Tumor Rupture
25%
Tumor-like Lesions
50%
Medicine and Dentistry
Adverse Event
20%
Anemia
20%
Anorexia
20%
Area under the Curve
40%
Arm
100%
Cancer Research
40%
Carboplatin
40%
Chemotherapy
100%
Cisplatin
100%
Diseases
20%
Dose Densification
100%
Doxorubicin
60%
Event Free Survival
20%
Febrile Neutropenia
20%
Fetoprotein
20%
Hepatectomy
20%
Hepatoblastoma
100%
Infection
20%
Intention-to-Treat Analysis
20%
Liver Transplantation
20%
Lung Metastasis
20%
Median Follow Up
20%
Metastasectomy
20%
Metastatic Carcinoma
20%
Mucositis
20%
Mycosis
20%
Neutropenia
40%
Ototoxicity
40%
Overall Survival
20%
Preoperative Chemotherapy
60%
Radical Surgery
20%
Side Effect
20%
Thrombocytopenia
20%
Tumor
100%